Stock Research for OSIR


Featured Broker: Ally Invest

Get the due diligence for another stock.


OSIR Stock Chart & Research Data

The OSIR chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OSIR chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


OSIR Due diligence Resources & Stock Charts

The OSIR stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OSIR Detailed Price Forecast - CNN Money CNN View OSIR Detailed Summary - Google Finance
Yahoo View OSIR Detailed Summary - Yahoo! Finance Zacks View OSIR Stock Research & Analysis -

Stock Analysis

TradeIdeas View OSIR Trends & Analysis - Trade-Ideas Barrons View OSIR Major Holders - Barrons
NASDAQ View OSIR Call Transcripts - NASDAQ Seeking View OSIR Breaking News & Analysis - Seeking Alpha
Spotlight View OSIR Annual Report - OTC Report View OSIR OTC Short Report -
TradeKing View OSIR Fundamentals - TradeKing Charts View OSIR SEC Filings - Bar Chart
WSJ View Historical Prices for OSIR - The WSJ Morningstar View Performance/Total Return for OSIR - Morningstar
MarketWatch View the Analyst Estimates for OSIR - MarketWatch CNBC View the Earnings History for OSIR - CNBC
StockMarketWatch View the OSIR Earnings - StockMarketWatch MacroAxis View OSIR Buy or Sell Recommendations - MacroAxis
Bullish View the OSIR Bullish Patterns - American Bulls Short Pains View OSIR Short Pain Metrics -

Social Media Mentions

StockTwits View OSIR Stock Mentions - StockTwits PennyStocks View OSIR Stock Mentions - PennyStockTweets
Twitter View OSIR Stock Mentions - Twitter Invest Hub View OSIR Investment Forum News - Investor Hub
Yahoo View OSIR Stock Mentions - Yahoo! Message Board Seeking Alpha View OSIR Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for OSIR - Insider Cow View Insider Transactions for OSIR - Insider Cow
CNBC View OSIR Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OSIR - OTC Markets
Yahoo View Insider Transactions for OSIR - Yahoo! Finance NASDAQ View Institutional Holdings for OSIR - NASDAQ

Stock Charts

FinViz View OSIR Stock Insight & Charts - StockCharts View OSIR Investment Charts -
BarChart View OSIR Stock Overview & Charts - BarChart Trading View View OSIR User Generated Charts - Trading View

Latest Financial News for OSIR

The Daily Biotech Pulse: Morphosys Expands Collaboration, Osiris Announces Product Launch, Argenx To Offer Shares
Posted on Tuesday September 18, 2018

The following are top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Sept. 17.) Champions Oncology Inc (NASDAQ: CSBR ) Emergent Biosolutions ...

Osiris Therapeutics, Inc. Announces GrafixPL PRIME™ Launches October 1, 2018
Posted on Monday September 17, 2018

COLUMBIA, Md., Sept. 17, 2018-- Osiris Therapeutics, Inc., a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announces that ...

The Daily Biotech Pulse: Regulatory Roadblock For Akcea-Ionis, Affimed's Alliance, FDA Nod For Tetraphase's Antibiotic
Posted on Tuesday August 28, 2018

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Biotech Stocks hitting 52-week highs on Aug. 27) Abbott Laboratories (NYSE: ABT ) Ascendis Pharma A/S ...

Osiris Therapeutics, Inc. Announces Peer-Reviewed Publication Comparing the Efficacy of Viable Cryopreserved Placental Membranes to Human Fibroblast-Derived Dermal Substitute in the Treatment of Chronic Diabetic Foot Ulcers (DFUs) in a Multicenter Randomized Clinical Trial
Posted on Monday August 27, 2018

Dermagraft® (1) is a bioengineered human fibroblast-derived dermal substitute product that has been on the U.S. market for more than 15 years (2, 3).  Grafix® is a cryopreserved placental tissue allograft that has been developed using a proprietary cryopreservation method. This method allows the retention of intact matrix, growth factors and cells native to placental tissue.  Prior clinical studies have shown the safety and efficacy of both Grafix and Dermagraft when used in the treatment for chronic DFUs in their respective trials (4, 5). The study’s objective was to compare clinical outcomes and product cost between Grafix and Dermagraft as an adjunct to standard of care (SOC) in the treatment of chronic DFUs in a prospective, multicenter, single-blind study.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.